nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—CHRNB4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Parkinson's disease	0.0411	0.0467	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Parkinson's disease	0.0376	0.0427	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—PPP1R1B—Parkinson's disease	0.034	0.0386	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0336	0.0382	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0307	0.0349	CbGpPWpGaD
Mecamylamine—CHRNB4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0286	0.0325	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0274	0.0311	CbGpPWpGaD
Mecamylamine—CHRNB4—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0267	0.0303	CbGpPWpGaD
Mecamylamine—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0262	0.0297	CbGpPWpGaD
Mecamylamine—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0244	0.0277	CbGpPWpGaD
Mecamylamine—CHRNB4—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0236	0.0268	CbGpPWpGaD
Mecamylamine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0233	0.0265	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DDC—Parkinson's disease	0.0232	0.0263	CbGpPWpGaD
Mecamylamine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0218	0.0247	CbGpPWpGaD
Mecamylamine—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0216	0.0245	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—SLC18A2—Parkinson's disease	0.0197	0.0224	CbGpPWpGaD
Mecamylamine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0192	0.0219	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Parkinson's disease	0.0156	0.0177	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD3—Parkinson's disease	0.014	0.016	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—TH—Parkinson's disease	0.0129	0.0147	CbGpPWpGaD
Mecamylamine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—Parkinson's disease	0.0127	0.0144	CbGpPWpGaD
Mecamylamine—CHRNA3—forebrain—Parkinson's disease	0.0117	0.0978	CbGeAlD
Mecamylamine—CHRNB4—head—Parkinson's disease	0.0109	0.0913	CbGeAlD
Mecamylamine—CHRNA2—forebrain—Parkinson's disease	0.0109	0.0909	CbGeAlD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.0108	0.0122	CbGpPWpGaD
Mecamylamine—CHRNB4—nervous system—Parkinson's disease	0.0104	0.0866	CbGeAlD
Mecamylamine—CHRNB4—central nervous system—Parkinson's disease	0.00998	0.0833	CbGeAlD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00849	0.00965	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00816	0.00927	CbGpPWpGaD
Mecamylamine—CHRNB4—brain—Parkinson's disease	0.00792	0.0662	CbGeAlD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00777	0.00882	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—HCN3—Parkinson's disease	0.00759	0.00862	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00733	0.00833	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—HCN3—Parkinson's disease	0.00694	0.00789	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00693	0.00787	CbGpPWpGaD
Mecamylamine—CHRNA3—head—Parkinson's disease	0.00671	0.056	CbGeAlD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.0067	0.00762	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00638	0.00725	CbGpPWpGaD
Mecamylamine—CHRNA3—nervous system—Parkinson's disease	0.00636	0.0531	CbGeAlD
Mecamylamine—CHRNA2—head—Parkinson's disease	0.00623	0.0521	CbGeAlD
Mecamylamine—CHRNA2—Neuronal System—HCN3—Parkinson's disease	0.00619	0.00704	CbGpPWpGaD
Mecamylamine—CHRNA3—central nervous system—Parkinson's disease	0.00612	0.0511	CbGeAlD
Mecamylamine—CHRNA3—cerebellum—Parkinson's disease	0.00598	0.05	CbGeAlD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00598	0.0068	CbGpPWpGaD
Mecamylamine—CHRNA2—nervous system—Parkinson's disease	0.00591	0.0494	CbGeAlD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00584	0.00663	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00574	0.00652	CbGpPWpGaD
Mecamylamine—CHRNA2—central nervous system—Parkinson's disease	0.00569	0.0475	CbGeAlD
Mecamylamine—CHRNA2—cerebellum—Parkinson's disease	0.00556	0.0465	CbGeAlD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00551	0.00626	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00525	0.00596	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00521	0.00592	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00509	0.00579	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00504	0.00573	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—KCNJ4—Parkinson's disease	0.00489	0.00556	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00488	0.00554	CbGpPWpGaD
Mecamylamine—CHRNA3—brain—Parkinson's disease	0.00486	0.0406	CbGeAlD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00468	0.00532	CbGpPWpGaD
Mecamylamine—CHRNA2—brain—Parkinson's disease	0.00452	0.0377	CbGeAlD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.0045	0.00511	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—KCNJ4—Parkinson's disease	0.00447	0.00508	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00446	0.00507	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00431	0.0049	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—DLG1—Parkinson's disease	0.00422	0.0048	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—KCNJ4—Parkinson's disease	0.00399	0.00453	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00398	0.00452	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00394	0.00448	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—DLG1—Parkinson's disease	0.00386	0.00439	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00374	0.00425	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00367	0.00417	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00355	0.00403	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00352	0.004	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—DLG1—Parkinson's disease	0.00345	0.00391	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00343	0.00389	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00342	0.00388	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00335	0.00381	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIK1—Parkinson's disease	0.0033	0.00375	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.0033	0.00375	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00325	0.00369	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00325	0.00369	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00322	0.00365	CbGpPWpGaD
Mecamylamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00314	0.00357	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00305	0.00347	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIK1—Parkinson's disease	0.00302	0.00343	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00299	0.0034	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00294	0.00334	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.0029	0.00329	CbGpPWpGaD
Mecamylamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00287	0.00327	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00284	0.00323	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00281	0.00319	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIK2—Parkinson's disease	0.00281	0.00319	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC18A2—Parkinson's disease	0.00272	0.00309	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIK1—Parkinson's disease	0.0027	0.00306	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00262	0.00298	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00258	0.00293	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00257	0.00292	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIK2—Parkinson's disease	0.00257	0.00292	CbGpPWpGaD
Mecamylamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00256	0.00291	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC18A2—Parkinson's disease	0.00249	0.00283	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00242	0.00275	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.0024	0.00272	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00236	0.00268	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00236	0.00268	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00233	0.00265	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00231	0.00263	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00229	0.00261	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIK2—Parkinson's disease	0.00229	0.0026	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC18A2—Parkinson's disease	0.00222	0.00252	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00221	0.00251	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00216	0.00245	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—CHRNA4—Parkinson's disease	0.00215	0.00245	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00213	0.00242	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.0021	0.00239	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00205	0.00233	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00198	0.00225	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—HSPA8—Parkinson's disease	0.00197	0.00224	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00197	0.00224	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—CHRNA4—Parkinson's disease	0.00197	0.00224	CbGpPWpGaD
Mecamylamine—CHRNB4—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00197	0.00223	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00196	0.00222	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00193	0.00219	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.0019	0.00216	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—DLG4—Parkinson's disease	0.00185	0.0021	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00181	0.00206	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—GRIN2B—Parkinson's disease	0.00181	0.00206	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—HSPA8—Parkinson's disease	0.00181	0.00205	CbGpPWpGaD
Mecamylamine—CHRNA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.0018	0.00204	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—SLC6A3—Parkinson's disease	0.00178	0.00203	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—CHRNA4—Parkinson's disease	0.00176	0.002	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—DLG4—Parkinson's disease	0.00169	0.00192	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—GRIN2B—Parkinson's disease	0.00166	0.00188	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—SLC6A3—Parkinson's disease	0.00163	0.00185	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00162	0.00184	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—HSPA8—Parkinson's disease	0.00161	0.00183	CbGpPWpGaD
Mecamylamine—CHRNA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.0016	0.00182	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—COMT—Parkinson's disease	0.00152	0.00172	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—DLG4—Parkinson's disease	0.00151	0.00172	CbGpPWpGaD
Mecamylamine—CHRNB4—Neuronal System—MAOA—Parkinson's disease	0.00151	0.00171	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—GRIN2B—Parkinson's disease	0.00148	0.00168	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—SLC6A3—Parkinson's disease	0.00146	0.00165	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—COMT—Parkinson's disease	0.00139	0.00158	CbGpPWpGaD
Mecamylamine—CHRNA3—Neuronal System—MAOA—Parkinson's disease	0.00138	0.00157	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—COMT—Parkinson's disease	0.00124	0.00141	CbGpPWpGaD
Mecamylamine—CHRNA2—Neuronal System—MAOA—Parkinson's disease	0.00123	0.0014	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00116	0.00132	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00116	0.00131	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000841	0.000955	CbGpPWpGaD
Mecamylamine—CHRNB4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000679	0.000771	CbGpPWpGaD
